IFPMA Corporate Brochure 2016
At IFPMA, we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Read more
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is responsible for the development, manufacture, and supply of medicines. Do your bit, play your part! www.ifpma.org and...
Read morePharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is responsible for the development, manufacture, and supply of medicines. Do your bit, play your part! www.ifpma.org...
Read moreNote to our readers: This is a re-posting that first appeared in Health Affairs Blog Here is something you don’t see too often: a room full of delegates at the World Health Organization (WHO), taking a break from discussions to practice Tai Chi. But so went proceedings at the First Global Meeting of National NCD Program...
Read moreIFPMA 2016 interview series on ‘The R&D challenges in tackling Zika virus’ As part of our latest interview series, we sat down with Dr. Ted Tsai to discuss the current R&D challenges in the fight against Zika virus. Dr. Ted Tsai, a vaccine expert from Takeda, took part in the World Health Organization (WHO)...
Read more‘Biotherapeutic medicines: a winning formula for patients’ – Hear what healthcare stakeholders and regulatory experts are saying today about the opportunities & challenges facing biotherapeutic medicines.
Read moreOur take on Zika virus Geneva, 3 March 2016 − The International Federation of Pharmaceutical Manufacturers and Associations, IFPMA, which includes some of the world’s leading manufacturers of vaccines, confirms that there is currently no approved vaccine or treatment for Zika virus (ZIKV) available. On 1 February 2016, the World Health Organization (WHO) declared the...
Read moreAt IFPMA, we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Read more
This piece was originally published on SciDev.Net. View the original piece and read more news and analysis on science and development at SciDev.Net. The global counterfeit drug trade, a multi-billion dollar industry, is thriving across Africa. For mothers trying to buy life-saving medicines for their children, a trip to the pharmacy or drug shop can...
Read morePharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is responsible for the development, manufacture, and supply of medicines. Do your bit, play your part! www.ifpma.org and...
Read moreIn the context of the cooperation in the fight against doping in sport, companies can use this template to undertake a review of project compounds (from candidate selection onward) to assess potential for risk for doping potential. This information will be reviewed internally for risk classification consisting of: A) no or negligible risk, B) possible...
Read moreCancer is one of the greatest health challenges of our time, and a leading cause of death in every corner of the world. Within the next two decades it is expected we reach 22 million new cases of cancer each year, the majority of them in low-and middle-income countries (LMICs). Without the preventative measures, the...
Read more